InVitro International: The Irvine test kit company...
InVitro International: The Irvine test kit company said its net loss for the third fiscal quarter ended June 30 narrowed to $341,000, or 3 cents a share, from $637,000, or 6 cents a share, for the same period a year ago. Revenue for the quarter ended June 30 was up 24% to $327,000 from $263,000. For the nine-month period, the company lost $1.3 million, or 11 cents a share, compared with a loss of $2 million, or 17 cents a share, for the corresponding period a year ago. Revenue increased slightly to $812,000 from $806,000.
Sign up for The Wild
We’ll help you find the best places to hike, bike and run, as well as the perfect silent spots for meditation and yoga.
You may occasionally receive promotional content from the Los Angeles Times.
